nfl

Jalen Hurts Ruled Out Against Panthers Due to Calf Blood Clot

SportsNow Editorial Desk2 min readNew story
Jalen Hurts Ruled Out Against Panthers Due to Calf Blood Clot
Image delivered by ESPN CDN

Philadelphia Eagles quarterback Jalen Hurts has been ruled out for Sunday's game against the Carolina Panthers after a follow-up ultrasound revealed movement in a calf blood clot.

Philadelphia Eagles quarterback Jalen Hurts will miss Sunday's game against the Carolina Panthers due to a superficial blood clot in his calf. The team announced the decision Thursday after a Wednesday night ultrasound revealed movement in the clot. Tanner McKee is expected to start in place of the 28-year-old quarterback, who has recorded 933 passing yards, eight touchdowns, and three interceptions through the 2026 season.

The injury originated when Hurts was cleated during an October 4th game against the Los Angeles Rams. Despite practicing in full on October 7th and 8th, Hurts sought treatment for calf pain last Thursday. An initial ultrasound performed in London on Saturday confirmed the presence of the superficial clot, but medical staff cleared him to play in the team's 19-17 loss to the Jacksonville Jaguars. In that contest, Hurts completed 21 of 40 passes for 220 yards and one touchdown while using a stationary bike between series.

Following the game in London and the return flight to Philadelphia, doctors recommended a follow-up scan within 72 hours. While Hurts practiced in full this past Wednesday, the subsequent imaging showed the clot had moved, prompting the team to prioritize his health and safety. The Eagles remain in communication with the NFL office regarding the treatment process for the former MVP, who is currently playing under a five-year, $255 million contract extension.

Stay informed

Follow SportsNow.

Join the reader list for future briefings and important newsroom updates.

Join for future newsroom briefings and important SportsNow updates.

No spam. Unsubscribe in one click from every email.

Reader conversation

Your take on the story

Stay with the story

Related coverage

Open desk